Prophylaxis against Venous Thromboembolism in Ambulatory Patients with Cancer
New England Journal of Medicine
This article outlines the risks and rates of VTE from trial data, discusses US guidance which overall does not endorse routine prophylaxis, and concludes that further studies on morbidity, mortality, and cost for this patient population are required.
NICE issues Final Appraisal Determination on prasugrel with PCI for treating ACS
National Institute for Health and Care Excellence
NICE has issued DRAFT guidance (FAD) recommending the use of prasugrel 10mg in combination with aspirin as an option for preventing atherothrombotic events in adults with acute coronary syndrome having primary or delayed percutaneous coronary intervention.
Biospace Inc.
A new study (RE-CIRCUIT™) will investigate the safety and efficacy of uninterrupted anticoagulant treatment with dabigatran (Pradaxa®) in patients with atrial fibrillation who undergo ablation. Results of the study are expected in 2016.
The above records have been identified by UKMi and feature in the NICE Medicines Awareness Service. Further details on this service can be found at:
http://www.evidence.nhs.uk/about-evidence-services/content-and-sources/medicines-information/new-medicines-awareness-services
